COMMUNIQUÉS West-GlobeNewswire

Clearside Biomedical Further Strengthens Commercial Organization With Appointment of Lester Rodríguez as Vice President, Quality
06/09/2018
ALPHARETTA, Ga., Sept. 06, 2018 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ: CLSD), a biopharmaceutical company dedicated to developing treatments that restore and preserve vision for people with serious eye [...]
Neon Therapeutics to Present at Morgan Stanley 16th Annual Global Healthcare Conference
06/09/2018
CAMBRIDGE, Mass., Sept. 06, 2018 (GLOBE NEWSWIRE) -- Neon Therapeutics, Inc. (Nasdaq: NTGN), a clinical-stage immuno-oncology company developing neoantigen-based therapeutics, today announced that management will [...]
Radius Health Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
06/09/2018
WALTHAM, Mass., Sept. 06, 2018 (GLOBE NEWSWIRE) -- Radius Health, Inc. (“Radius” or the “Company”) (Nasdaq:RDUS) today announced that the Company’s Board of Directors granted Dr. Charles Morris, in connection with his [...]
Profound Medical Files Preliminary Base Shelf Prospectus
06/09/2018
NOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER UNITED STATES WIRE SERVICES TORONTO, Sept. 06, 2018 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX:PRN; OTCQX:PRFMF) (“Profound” or the “Company”) announced today that [...]
Zealand sells royalty streams and milestones for USD 205 million to Royalty Pharma
06/09/2018
Company announcement - No. 21/ 2018 Zealand sells royalty streams and milestones for USD 205 million to Royalty Pharma Copenhagen, September 6, 2018 - Zealand Pharma A/S ("Zealand") (NASDAQ: ZEAL), a Copenhagen-based [...]
IRIDEX Announces FDA Clearance to Introduce Updated TruFocus LIO Premiere™ Laser Accessory to the U.S. Market
06/09/2018
MOUNTAIN VIEW, Calif., Sept. 06, 2018 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX) today announced the introduction of its updated TruFocus LIO Premiere™ laser accessory following U.S. Food and Drug [...]
GBT Announces New Employment Inducement Grants
06/09/2018
SOUTH SAN FRANCISCO, Calif., Sept. 06, 2018 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that, on September 4, 2018, the compensation committee of the Company’s board of [...]
Institutional Shareholder Services (ISS), Leading Proxy Advisor, Recommends Medigus Shareholders Vote “FOR” all Medigus’ Director Nominees
06/09/2018
-Medigus Implores Stockholders to Protect the Value of Their Investment and Vote “FOR” Medigus’ Director Nominees on the WHITE Proxy Card- OMER, Israel, Sept. 06, 2018 (GLOBE NEWSWIRE) -- Medigus Ltd. (“Medigus” or the [...]
Ascendis Pharma A/S Announces Presentations on Technology and Rare Disease Endocrinology Pipeline at September Conferences
06/09/2018
COPENHAGEN, Denmark, Sept. 06, 2018 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative TransCon™ technology to address significant unmet medical needs, today [...]
Replimune Announces FDA Acceptance of Investigational New Drug Application for its Lead Oncolytic Immunotherapy Candidate, RP1
06/09/2018
WOBURN, Mass., Sept. 06, 2018 (GLOBE NEWSWIRE) -- Replimune Group Inc. (NASDAQ: REPL), a biotechnology company developing oncolytic immunotherapies derived from its Immulytic™ platform, today announced the U.S. Food and [...]
Supernus Wins Appeal on Oxtellar XR® against TWi
06/09/2018
Second Appeal Win against Generic Filers ROCKVILLE, Md., Sept. 06, 2018 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN), a pharmaceutical company focused on developing and commercializing products for [...]
CORRECTING and REPLACING - Misonix Reports Record Fourth Quarter and Fiscal Year 2018 Revenue
06/09/2018
Fiscal Year 2018 Revenue Rises 35% to $36.7 Million FARMINGDALE, N.Y., Sept. 06, 2018 (GLOBE NEWSWIRE) -- On September 5, 2018, Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), issued a press release [...]
Orion Biotechnology acquires patent portfolio for potent CCR5 chemokine antagonist
06/09/2018
OTTAWA, Sept. 06, 2018 (GLOBE NEWSWIRE) -- Orion Biotechnology Canada Ltd., a developer of novel medical treatments, today announced that its subsidiary, Orion Biotechnology Switzerland Sàrl, has successfully closed a [...]
VALNEVA : Déclaration d'actions et de droits de vote Août 2018
06/09/2018
VALNEVA Déclaration d'actions et de droits de vote - AOUT 2018 Dénomination sociale : VALNEVA Adresse du siège social : 6 rue Alain Bombard, 44800 Saint-Herblain Marché réglementé Euronext Paris de Nyse Euronext - [...]
CROSSJECT : Information relative au nbre total de droits de vote et d'actions composant le capital social
06/09/2018
Communiqué de Presse Information relative au nombre total de droits de vote et d'actions composant le capital social Dijon, le 6 septembre 2018 CROSSJECT (ISIN : FR0011716265 ; Mnémo : ALCJ), « specialty pharma » qui [...]
OSE Immunotherapeutics Reports First-Half 2018 Results and Provides a Corporate Update
06/09/2018
Key Highlights: Entered into a global immuno-oncology agreement in April 2018 with Boehringer Ingelheim to develop myeloid checkpoint inhibitor OSE-172 able to modulate the SIRPa/CD47 axis; a third strategic structuring [...]
Integrated Cannabis Company, Inc. Provides Corporate Update
06/09/2018
VANCOUVER, British Columbia, Sept. 06, 2018 (GLOBE NEWSWIRE) -- Integrated Cannabis Company, Inc. (CSE: ICAN, OTCQB: ICNAF) (the “ Company ” or “ Integrated Cannabis ”), is pleased to provide a corporate update. [...]
ThromboGenics Business Update - H1 2018
06/09/2018
Press release 6 September 2018 Regulated Information Positive Topline Results for Diabetic Eye Disease Portfolio Shareholder approval for company name change to Oxurion NV €10 million equity investment from Novartis [...]
Sharecare to be featured at National Business Group on Health’s Workforce Strategy 2018
06/09/2018
ATLANTA, Sept. 06, 2018 (GLOBE NEWSWIRE) -- Sharecare, the digital health company that helps people manage all their health in one place, today announced that its senior vice president of product, Toni Pashley , will be [...]

Pages